Description: China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Home Page: www.shineway.com
No. 168 Shiluan Street
Shijiazhuang,
051430
China
Phone:
86 31 1880 30066
Officers
| Name | Title |
|---|---|
| Mr. Zhenjiang Li | Co-Founder & Exec. Chairman |
| Ms. Yunxia Xin | Co-Founder & Exec. Director |
| Mr. Huimin Li | Exec. Director |
| Mr. Bun Ching Lee | Financial Controller & Company Sec. |
| Mr. King Kuen Hung | Director of Investor Relation |
| Mr. Yudong Zhang | Gen. Mang. of Sales & Marketing |
| Mr. Tiejun Liu | Exec. Director |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 5.435 |
| Price-to-Book MRQ: | 0.5757 |
| Price-to-Sales TTM: | 0.2375 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3871 |